BOSTON, MA, Nanite Inc. announced an investment from the Cystic Fibrosis Foundation of up to $2 million
Nanite Inc. announced an investment from the Cystic Fibrosis Foundation of up to $2 million to develop gene delivery technologies for the lung. This investment builds on the $6M seed financing recently announced by the company.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.